MedTrace Logo

Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth

NCT00295464 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 440

Last updated 2006-05-03

No results posted yet for this study

Summary

Administration of steroid to the mother in imminent preterm delivery is a known effective practice to decrease the risk of respiratory distress syndrome and intraventricular haemorrhage in preterm infants if given with a week of the preterm delivery. This randomized clinical trial is performed to test the possibility whether the repeat dose of steroid results in further reduction of these diseases in case the mother is in imminent preterm delivery more than a week after the first antenatal steroid treatment.

Conditions

  • Respiratory Distress Syndrome
  • Intraventricular Haemorrhage

Interventions

DRUG

Betamethasone sodium phos (drug)

Sponsors & Collaborators

  • University of Oulu

    lead OTHER

Principal Investigators

  • Mikko N Hallman, MD · Children's Hospital, Univ. of Oulu

  • Outi M Peltoniemi, MD · Children's Hospital, Univ. of Oulu

  • Pentti Jouppila, MD · Oulu Central Hospital, Dept. of Obstetrics & Gynecology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-05-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00295464 on ClinicalTrials.gov